Our investigation also showed that the addition of a neutralizing anti-IGFBP2 antibody suppressed migration and invasiveness of ESCC cells, induced by their co-culture with CAF-like cells. This evidence concerns the gene IGFBP2 and esophageal squamous cell carcinoma.